B.H.E. Jansen
Amsterdam University Medical Centers, Cancer Center Amsterdam
Papers
7
Total Citations
358
H-Index
6
About
Dr. B.H.E. Jansen is a leading researcher in prostate cancer imaging, specializing in the application of PSMA PET/CT and PET/MRI for improved diagnosis, staging, and treatment planning. Their major contributions center on validating the clinical utility of [18F]DCFPyL PET tracers, demonstrating their superiority over conventional imaging for detecting lymph-node metastases and localizing clinically significant prostate cancer. Dr. Jansen’s work has been highly influential, with their landmark SALT trial (106 citations) and machine learning radiomics study (135 citations) providing critical evidence for integrating PSMA PET into routine practice. They have also advanced the field by comparing PSMA PET/MRI to multiparametric MRI (ProStaPET study, 27 citations) and by refining the use of preoperative MRI to improve surgical outcomes. With over 350 total citations across their most-cited papers, Dr. Jansen’s research has directly shaped contemporary guidelines for primary prostate cancer staging and salvage radiation therapy, making them a pivotal figure in the transition toward precision molecular imaging in uro-oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7